There is a protective sugar coating on brain vessels that was once thought to be insignificant. But as it turns out, this sugar shield plays a key role in preventing cognitive decline. Pioneering research discussed in a promising Geonic Press Interview published in Brain Medicine suggests that restoring this layer reversed damage and memory loss in again brains and potentially provides a new approach to treating neurodegenerative diseases.
Discovering the Importance of the Sugar Shield
Under the mentorship of Nobel laureate Carolyn Bertozzi and renowned neurobiologist Tony Wyss-Coray, Stanford Chemistry PhD graduate Dr. Shi’s interdisciplinary approach tackled several significant challenges, such as how to study molecules so complex they resist traditional analysis methods, and what techniques capture the dynamic nature of glycosylation in living brain tissues. Her innovative solutions highlight the power of cross-disciplinary thinking in biomedical research.
This research, recently published in Nature, which could fundamentally change the understanding of brain aging, was conducted by Sophia Shi, PhD. The work focuses on the glycocalyx, a complex “forest” of sugar molecules coating blood-brain-barrier (BBB) endothelial cells. Dr. Shi demonstrated that the protective sugar shield dramatically deteriorates with age, which results in BBB dysfunction and neuroinflammation, both of which are key drivers of cognitive decline and neurodegenerative diseases.
“Post-translational modifications like glycosylation have been understudied for too long,” said Dr. Shi. “These modifications can completely transform protein function, yet we’re only beginning to understand their role in brain health and disease.” Her work positions glycoscience at the forefront of neurodegeneration research, challenging long-held assumptions about therapeutic targets.
“The glycocalyx acts like a protective shield for the brain’s blood vessels,” Dr. Shi explains. “When we restored these critical sugar molecules in aged mice, we saw remarkable improvements in both barrier integrity and cognitive function.” This is the first time scientists have successfully reversed age-related BBB dysfunction through glycocalyx restoration.
Imagine the Possibilities
The implications of these findings are nothing short of profound. Identifying specific mucin-type O-glycans as being critical for BBB integrity, offering molecular targets for drug development. This approach could very well lead to treatments that may address the root causes of neurodegeneration rather than the current status quo of merely managing symptoms.
Imagine the possibilities; can this discovery slow the progression of Alzheimer’s disease, or if we find out what influences glycocalyx health and how early in aging the sugar shield begins to deteriorate, could we restore the protective molecules before they begin to deteriorate to prevent brain wasting disease?
Questions such as this are what will be influencing the next phase of her newly launched cutting-edge research program at Harvard’s Rowland Institute. Uncovering these answers could dramatically shift preventive approaches to preserving brain health. Moving the current perspective of viewing the BBB as a wall to understanding the sugar-coated interface is a paradigm shift bridging neuroscience with glycobiology that requires innovative approaches and a richer narrative, which may explain why previous approaches targeting the BBB have had limited success.
Receiving recognition with the David S. Miller Young Scientist Award at the Cerebral Vascular Biology Conference, Dr. Shi’s insight, vision, and research on developing glycan-based therapies to combat brain aging offer hope for people around the World who are affected by age-related cognitive decline and neurodegenerative diseases.
As with anything you read on the internet, this article should not be construed as medical advice; please talk to your doctor or primary care provider before changing your wellness routine. WHN does not agree or disagree with any of the materials posted. This article is not intended to provide a medical diagnosis, recommendation, treatment, or endorsement. Additionally, it is not intended to malign any religion, ethnic group, club, organization, company, individual, or anyone or anything. These statements have not been evaluated by the Food and Drug Administration.
Content may be edited for style and length.
References/Sources/Materials provided by:
